{"id":"W4391779877","doi":"10.1038/s41591-024-02808-y","title":"Biomarker-directed targeted therapy plus durvalumab in advanced non-small-cell lung cancer: a phase 2 umbrella trial","year":2024,"lang":"en","type":"article","venue":"Nature Medicine","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":116,"is_retracted":false,"has_abstract":true,"ca_institutions":"Alberta Cancer Foundation; William Osler Health System; Centre Hospitalier de l’Université de Montréal; University of Toronto; University Health Network; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"Daiichi Sankyo Europe; Chugai Pharmaceutical; University of Texas MD Anderson Cancer Center; EMD Serono; Foundation Medicine; Karl Landsteiner Privatuniversität für Gesundheitswissenschaften; Universitätsklinikum Heidelberg; Ipsen; Deutsches Zentrum für Lungenforschung; Ottawa Hospital Research Institute; Seoul National University Hospital; Eisai; Universität Wien; PharmaMar; Institut Bergonié; Seoul National University; University of Toronto; Sanofi; Sungkyunkwan University; College of Medicine, Seoul National University; Genentech; Institut Gustave-Roussy; EpicentRx; Pfizer; Incyte; Mirati Therapeutics; Teva Pharmaceutical Industries; University of Ottawa; Johns Hopkins University; Nationales Centrum für Tumorerkrankungen Heidelberg; Amgen; Deutsches Krebsforschungszentrum; Université de Montréal; Samsung; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Regeneron Pharmaceuticals","keywords":"Durvalumab; Medicine; Immunotherapy; Oncology; Internal medicine; Lung cancer; Cancer; Immunology; Cancer research; Nivolumab","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008416325,0.0005343577,0.001014931,0.0007510238,0.00008512279,0.00003033397,0.0002566779,0.0006976107,0.001502682],"category_scores_gemma":[0.0001532567,0.000377121,0.0002690921,0.002260389,0.0001944679,0.00009959291,0.00003129353,0.001502348,0.000009969606],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007451063,"about_ca_system_score_gemma":0.001057202,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001047446,"about_ca_topic_score_gemma":0.0002587698,"domain_scores_codex":[0.9968513,0.0001335021,0.0008173528,0.0008531619,0.0007060273,0.0006386891],"domain_scores_gemma":[0.9986008,0.000293581,0.0001526492,0.0005484782,0.0001668055,0.0002377191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.2572039,0.0007918483,0.0003091214,0.000923552,0.0007784345,0.001037197,0.002290206,0.000005079828,0.4542488,0.00001076313,0.04646213,0.2359389],"study_design_scores_gemma":[0.6589808,0.00587684,0.003819458,0.006075001,0.0005641829,0.0001349302,0.0004721613,0.01573326,0.04253775,0.00003107821,0.264862,0.0009124464],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.7134558,0.2697655,0.00005121093,0.005736144,0.005001679,0.002588364,0.00004319034,0.0004002925,0.002957823],"genre_scores_gemma":[0.9685972,0.02118577,0.0002526394,0.002877003,0.0018586,0.0003777026,0.0002793161,0.0001277459,0.004443959],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4117111,"threshold_uncertainty_score":0.9998681,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01803103236702123,"score_gpt":0.3536915487600901,"score_spread":0.3356605163930689,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}